Trial of Antibody Drug for COVID-19 Stopped for Lack of Effectivenes
TUESDAY, Oct. 27, 2020 (HealthDay News) — Testing of Eli Lilly’s antibody drug for hospitalized COVID-19 patients has been halted because the treatment doesn’t help them recover from their infection. Two weeks ago, enrollment in the study was paused because of a possible safety issue, the Associated Press reported. ButContinue Reading









